Human sensory neuron-specific G-protein-coupled receptors (SNSRs) are expressed solely in small diameter primary sensory neurons. This restricted expression pattern is of considerable therapeutic interest because small nociceptors transmit chronic pain messages. The neuronal function of human SNSRs is difficult to assess because rodent orthologs have yet to be clearly defined, and individual isoforms are found only in a small subset of primary sensory neurons. To circumvent this problem, we expressed human SNSR4 (hSNSR4; also known as Hs.mrgX1) in rat superior cervical ganglion (SCG), dorsal root ganglion (DRG), and hippocampal neurons using nuclear injection or recombinant adenoviruses and examined modulation of ion channels and neurotransmission using whole-cell patch-clamp techniques. BAM8 -22 (a 15 amino acid C-terminal fragment of bovine adrenal medulla peptide 22), a peptide agonist derived from proenkephalin, inhibited high (but not low) voltage-activated Ca 2ϩ current in both DRG and SCG neurons expressing hSNSR4, whereas no response was detected in control neurons. The Ca 2ϩ current inhibition was concentration dependent and partially sensitive to Pertussis toxin (PTX) treatment. Additionally, the peptide was highly effective in modulating current arising from M-type K ϩ channels in SCG neurons expressing hSNSR4. In hippocampal neurons expressing hSNSR4, BAM8 -22 induced presynaptic inhibition of transmission that was abolished after PTX treatment. Our data indicate that hSNSR4, when heterologously expressed in rat neurons, can be activated by an opioid-related peptide, couples to G q/11 -proteins as well as PTX-sensitive G i/o -proteins, and modulates neuronal Ca 2ϩ channels, K ϩ channels, and synaptic transmission.
Introduction
Painful stimuli are initially detected at the peripheral terminals of specialized primary sensory neurons called nociceptors. Thus, proteins that mediate action potential initiation, propagation, and neurotransmission in these neurons are potential therapeutic targets for the development of novel analgesics. Of particular interest are proteins that are expressed predominantly, if not exclusively, in primary sensory neurons. Such a restricted expression pattern would help limit the actions of selective agents to the peripheral nervous system and presumably avoid undesirable CNS side effects such as mental impairment and dependence. In this regard, several ion channels have been reported that are expressed primarily in small nociceptive neurons. These include a voltage-gated tetrodotoxin-insensitive Na ϩ channel (Na V 1.8), an ATP-gated ion channel (P2X 3 receptor), and a nonselective cationic channel (vanilloid receptor VR1) activated by capsaicin, noxious heat, and extracellular protons ). In each case, genes encoding orthologous proteins have been identified from murine and human genomes, thus facilitating the construction of mouse knock-out models. Such models have been useful in evaluating the participation of the targeted gene in conveying painful stimuli to the CNS.
Recently, a large family of heterotrimeric G-protein-coupled receptors (GPCRs) was identified with an expression pattern restricted to primary sensory neurons using a subtractive strategy to identify a cDNA population specific to trkA-expressing neurons (Dong et al., 2001 ). The receptor family was termed mrg for Mas-related genes (Young et al., 1986) , and numerous members were identified in the rat, mouse, and human genome. An independent search by Lembo et al. (2002) based on a rat orphan GPCR sequence identified six human genes, which they termed sensory neuron-specific G-protein-coupled receptors (SNSRs). Three of the genes found by the two groups appear to be identical: Hs.mrgX1 and human SNSR4 (hSNSR4); Hs.mrgX3 and hSNSR1; Hs.mrgX4 and hSNSR6. Surprisingly, clear orthologous relationships between interspecies subfamily members are not apparent (Choi and Lahn, 2003; Zylka et al., 2003) , although the human genes share highest homology with the mrgA subfamily of murine genes.
Given the properties of these receptors, it will be challenging to delineate physiological functions. First, endogenous ligands have not been unequivocally identified, although interesting candidates are beginning to emerge (Dong et al., 2001; Bender et al., 2002; Han et al., 2002; Lembo et al., 2002; Robas et al., 2003) . Second, these receptors appear to be expressed in a very small subset of nociceptors; thus, in the absence of a method of identifying expressing neurons, a very large number of neurons would need to be sampled to obtain meaningful results. Third, it is not clear whether receptor protein is expressed throughout the neuron or restricted to a specific compartment (e.g., nerve terminals). Finally, as noted above, the function of the human receptors may not be accurately inferred from studying rodent receptors in situ. To circumvent these problems, we heterologously expressed hSNSR4 in rat dorsal root ganglion (DRG), superior cervical ganglion (SCG), and hippocampal neurons using nuclear injection or recombinant adenoviruses and examined modulation of ion channels and neurotransmission using wholecell patch-clamp techniques.
Materials and Methods
All experiments were approved by the Institutional Animal Care and Use Committee.
Cell cultures. Single SCG neurons were isolated from 10-to 14-weekold male Wistar rats as described previously (Ikeda, 2004) . Briefly, after dissection, the ganglia were desheathed, cut into small pieces, and incubated with 0.7 mg/ml collagenase type D (Roche Molecular Biochemicals, Indianapolis, IN), 0.4 mg/ml trypsin (Worthington Biochemical, Lakewood, NJ), and 0.1 mg/ml DNase 1, type IV (Sigma, St. Louis, MO) in minimal essential medium (MEM) saturated with 5% CO 2 /95% O 2 at 35°C for 1 hr. Thereafter, cells were dissociated by vigorous shaking of the flask. After centrifugation twice at 50 ϫ g, the dispersed neurons were resuspended in MEM containing 10% fetal bovine serum, 1% glutamine, and 1% penicillin-streptomycin solution (all from Invitrogen, Carlsbad, CA). Neurons were then plated into polystyrene culture dishes coated with poly-L-lysine and stored in a humidified atmosphere containing 5% CO 2 in air at 37°C. Single DRG neurons were isolated from 1-to 2-weekold Sprague Dawley rats using essentially the same procedure, except the collagenase concentration was reduced to 0.1 mg/ml. Hippocampal neurons were grown on collagen/poly-D-lysine microislands as reported previously (Bekkers and Stevens, 1991; Chen and Lambert, 2000) . Briefly, hippocampi were dissected from newborn Sprague Dawley rats and digested with papain (ϳ25 U/ml) at 37°C for 1 hr. After dissociation, 5 ϫ 10 4 cells were plated in 35 mm dishes that had been coated with 0.15% agarose and sprayed with a 1:4 (v/v) mixture of rat tail collagen (3.6 mg/ml) and poly-D-lysine (0.5 mg/ml). Where indicated, SCG and DRG neurons were incubated overnight with 500 ng/ml Pertussis toxin (PTX; List Biological, Campbell, CA), and hippocampal neurons were incubated with 100 ng/ml PTX for 24 -72 hr before recording.
Intranuclear injection of SCG neurons. Because the coding region for hSNSR4 (GenBank accession number AF474990) contains no introns, the sequence was directly amplified from human genomic DNA (Promega, Madison, WI) with Pfu ultra polymerase (Stratagene, La Jolla, CA). The resulting PCR product was ligated into the multiple cloning region of pCI, a mammalian expression vector (Promega), at the EcoRIEcoRV site, and the sequence was confirmed by automated DNA sequencing. The forward primer was designed such that the start codon was under the optimal context for translational initiation (Kozak, 1999) . The hSNSR4 construct (pCI-hSNSR4; 0.1 g/l in 10 mM Tris, pH 8.0) was injected into the nucleus of SCG neurons 4 -8 hr after cell isolation with an Eppendorf (Brinkmann Instruments, Westbury, NY) FemtoJet microinjector and 5171 micromanipulator (Ikeda, 2004) . Neurons were coinjected with a plasmid, pEGFP-N1 (5 ng/l; Clontech, Palo Alto, CA), encoding the enhanced green fluorescent protein (EGFP) cDNA to facilitate later identification of successfully injected cells. SCG neurons expressing EGFP were used for whole-cell patch-clamp recordings within 24 hr after injection.
Adenoviral vectors and infection of DRG and hippocampal neurons.
Adenoviruses coexpressing EGFP and hSNSR4 were generated using the AdEasy system (He et al., 1998) . Briefly, the XhoI-EcoRV fragment of hSNSR4 coding region in the above pCI-hSNSR4 vector was subcloned into the shuttle vector pAdTrack-CMV (kindly provided by T.-C. He, Johns Hopkins University, Baltimore, MD). The shuttle vector has a separate EGFP expression cassette that allows visualization of virus production and identification of infected cells (He et al., 1998) . The resultant plasmid (pAdTrack-CMV-hSNSR4) was linearized with PmeI and electroporated into Escherichia coli BJ5183 cells that had been transformed with pAdEasy-1, an adenoviral backbone plasmid (Stratagene). Recombination between these two plasmids was confirmed by restriction analysis and sequencing. High-titer virus stocks were generated by transfecting PacI-linearized recombinant plasmids into human embryonic kidney (HEK) 293 cells. The crude lysate of virus-infected HEK 293 cells was used for experiments. The effective titer was calculated by counting the number of EGFP-positive cells in a 12-well plate ϳ40 hr after infection. Control adenoviruses expressing EGFP alone were generated similarly, except the shuttle vector was directly used for recombination. DRG neurons were infected 6 -12 hr after isolation by adding 3 ϫ 10 8 infectious units (diluted in MEM) to each 35 mm dish followed by replacement of the culture medium after 12 hr. Approximately 20 -30 hr after infection, infection efficiency was ϳ100% as judged from EGFP fluorescence, and whole-cell recordings were performed at this time. Hippocampal neurons (10 -14 d in vitro) were infected by adding 2-5 ϫ 10 7 infectious units per dish. Approximately 1 hr before infection, a glutamate receptor antagonist, D-2-amino-5-phosphonovaleric acid (100 -200 M), was added to minimize toxicity. Recordings of infected hippocampal neurons were performed 30 -60 hr after infection.
Electrophysiology. Whole-cell currents were recorded with a patchclamp amplifier (Axopatch 200B; Axon Instruments, Union City, CA) at room temperature (21-24°C) using the conventional whole-cell variant of the patch-clamp technique (Hamill et al., 1981) . For recording Ca 2ϩ current (I Ca ), patch electrodes were pulled from borosilicate glass capillaries (Corning 7052; Garner Glass, Claremont, CA) on a P-97 FlamingBrown micropipette puller (Sutter Instruments, Novato, CA), fire polished on a microforge, and filled with a solution containing (in mM): 120 N-methyl-D-glucamine, 20 tetraethylammonium (TEA)-OH, 10 HEPES, 11 EGTA, 1 CaCl 2 , 14 Tris-creatine phosphate, 4 MgATP, and 0.3 Na 2 GTP; pH was adjusted to 7.24 with methanesulfonic acid and HCl (final Cl Ϫ concentration of 20 mM). Pipette resistance ranged from 1 to 3 M⍀, yielding uncompensated series resistances of 2-6 M⍀. Series resistance compensation of 80% was used in all recordings. For recording I Ca from SCG neurons, the external solution consisted of the following: 145 mM TEA methanesulfonate, 10 mM HEPES, 15 mM glucose, 10 mM CaCl 2 , and 300 nM tetrodotoxin; pH 7.35 and 320 mOsm/kg. For recording I Ca from DRG neurons, the bathing solution CaCl 2 was reduced to 5 mM, and the HEPES increased by an identical amount. Low voltage-activated (LVA) I Ca from DRG neurons was evoked at Ϫ40 mV from a holding potential of Ϫ80 mV. High voltage-activated (HVA) I Ca from DRG neurons was evoked at ϩ10 mV. Because of the heterogeneity in DRG neuron I Ca composition, calculation of receptor-mediated inhibition of the HVA current component was determined from neurons in which I Ca(ϩ10) /I Ca(Ϫ40) ratio exceeded 1. This procedure helped exclude neurons in which a small HVA current component might be contaminated from residual LVA current. Voltage protocol generation and data acquisition were performed using custom data acquisition software on a Macintosh G4 computer (Apple Computers, Cupertino, CA) with an ITC-18 interface board (InstruTECH, Port Washington, NY). I Ca traces were low-pass filtered at 2-5 kHz and digitized at 10 kHz. For M-current (I M ) recordings, pipettes were pulled from borosilicate glass capillaries (1B150F-4; World Precision Instruments, Sarasota, FL) and filled with an internal solution that consisted of the following (in mM): 140 KCl, 0.1 EGTA, 10 HEPES, 4 MgATP, 0.1 Na 2 GTP, 0.1 Tris-creatine phosphate; pH adjusted to 7.25 with KOH, 300 mOsm/kg. The external solution contained the following: 150 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 1 mM MgCl 2 , 1 mM CaCl 2 , 15 mM glucose, 300 nM tetrodotoxin; pH adjusted to 7.35 with NaOH, 325 mOsm/kg. I M traces were low-pass filtered at 1 kHz and digitized at 2 kHz.
For recording synaptic currents, hippocampal neurons were depolarized every 10 sec with pairs (50 msec interval) of depolarizing command pulses (2 msec, 60 mV) from a holding potential between Ϫ40 and Ϫ60 mV. The depolarizations evoked unclamped action currents and synaptic (autaptic) currents (Bekkers and Stevens, 1991) . Series resistance (after compensation) was monitored during the recording, and cells were discarded if a significant increase occurred. Patch electrodes were pulled from borosilicate glass capillaries (TW150F-4; World Precision Instruments) and filled with a solution containing the following (in mM): 140 K-gluconate, 5 KCl, 0.2 EGTA, 10 HEPES, 3 MgATP, 0.3 Na 2 GTP; pH 7.25, 300 mOsm/kg. The external solution contained the following (in mM): 145 NaCl, 2.5 KCl, 10 HEPES, 10 glucose, 1.5 CaCl 2 , 2.5 MgCl 2 ; pH adjusted to 7.35 with NaOH, 320 mOsm/kg. Application of drugs to the neuron under study was performed by positioning a silica tube (inner diameter, 200 m) of a custom-designed gravity-fed microperfusion system at ϳ100 m from the cell. BAM8 -22 (a 15 amino acid C-terminal fragment of bovine adrenal medulla peptide 22; human, bovine, rat, and mouse sequences are identical) was synthesized by Invitrogen and used at 3 M unless otherwise indicated. The other drugs were purchased from Sigma unless otherwise stated. Numerical values are expressed as mean Ϯ SEM. Statistical comparisons were made by using paired, unpaired Student's t test or ANOVA followed by NewmanKeuls test as appropriate. The differences were considered significant if p Ͻ 0.05.
Results

Ca
2؉ channels in rodent DRG neurons are not modulated by the peptide BAM8 -22 Although the identities of endogenous ligands for hSNSRs are not known, a Ca 2ϩ mobilization assay was used to identify a proenkephalin A gene product, BAM22, as a high-potency agonist for hSNSR3/4 (Lembo et al., 2002) . BAM22 is a potent agonist at classical opioid receptor subtypes (e.g., , , ␦) as well as SNSRs. However, a truncation product of BAM22, BAM8 -22, lacks the characteristic Met-enkephalin motif YGGFM and is unable to activate classical opioid receptors while retaining high affinity for hSNSR4 (Lembo et al., 2002) .
We thus exploited the apparent specificity (at least in regard to opioid receptors) of BAM8 -22 to probe for native receptors coupling to Ca 2ϩ channels in rodent sensory neurons. DRG neurons express many types of voltage-dependent Ca 2ϩ channels (Fedulova et al., 1985; Kostyuk et al., 1988; Fox et al., 1987; Regan et al., 1991; Mintz et al., 1992; Yusaf et al., 2001) , and as shown in Figure  1 , the composition of I Ca varies considerably from cell to cell. To separate the effects of BAM8 -22 on I Ca arising from LVA and HVA Ca 2ϩ channels, a voltage protocol consisting of 30 msec test pulses to Ϫ40 mV and ϩ10 mV evoked from a holding potential of Ϫ80 mV was used ( Fig. 1 A, bottom) . The test pulses were separated by a 50 msec pulse to Ϫ60 mV, which inactivated the majority of LVA Ca 2ϩ channels. The current evoked at Ϫ40 mV should arise primarily from LVA (i.e., T-type) Ca 2ϩ channels because HVA Ca 2ϩ channels are not usually activated at Ϫ40 mV. I Ca recorded during the ϩ10 mV test pulse is enriched in the HVA current component, although a small fraction may still arise from the LVA component.
As shown in Figure 1 , A and D, application of BAM8 -22 (3 M) did not alter the amplitude of HVA or LVA I Ca recorded from young rat DRG neurons (0.04 Ϯ 0.98%, n ϭ 10, and 4.5 Ϯ 1.5%, n ϭ 5, respectively). BAM8 -22 (3 or 10 M) also had no effect on HVA or LVA I Ca recorded from adult mouse DRG neurons (data not shown; n ϭ 23). The majority of neurons were small to medium in size with a mean capacitance of 27.8 pF (range, 13.9 -63.8 pF). The lack of BAM8 -22 effect is consistent with the idea that hSNSRs/mrgs are not orthologous to rodent members of the same gene family. It is also possible that neurons sensitive to BAM8 -22 represent only a very small subset of all DRG neurons and thus were missed with the sample size used (41 Figure 1 . Heterologously expressed hSNSR4 couples to HVA but not LVA Ca 2ϩ channels in rat DRG neurons. A, Representative whole-cell patch-clamp I Ca traces acquired in the absence or presence of the peptide agonist BAM8 -22 (BAM; 3 M) from a control (Con; top) or an EGFP-expressing DRG neuron (middle). The voltage protocol used to evoke I Ca for experiments described in Fig. 1 is illustrated at the bottom. The current evoked at Ϫ40 mV arises from LVA Ca 2ϩ channels, whereas the current evoked at ϩ10 mV (after an inactivating interpulse) arises primarily for HVA Ca 2ϩ channels. B, Representative current traces (top) illustrating marked inhibition of I Ca evoked (ϩ10 mV) after application of BAM8 -22 to a DRG neuron expressing hSNSR4. The neuron illustrated exhibited virtually no LVA Ca 2ϩ channels. The time course of inhibition is shown at the bottom. C, Representative current traces (top) obtained in the absence or presence of BAM8 -22 from an hSNSR4-expressing DRG neuron with a large component of LVA-type Ca 2ϩ channels. The time course of inhibition is shown at the bottom. D, Summary bar graph comparing mean BAM8 -22-induced inhibition of HVA (filled) and LVA (open) I Ca under experimental conditions listed below each bar. HVA I Ca amplitude was measured 10 msec from the start of the voltage step to ϩ10 mV, whereas LVA I Ca amplitude was measured 15 msec after initiation of the voltage step to Ϫ40 mV. Heterologous expression was accomplished using recombinant adenovirus. neurons). Alternatively, it is possible that appropriate receptors may not be localized to neuronal soma, are altered by enzymatic treatment, or do not modulate I Ca under the recording conditions used (see below).
Heterologously expressed hSNSR4 couples to high but not low voltage-activated Ca
2؉ channels in DRG neurons Failure to detect a BAM8 -22 response in DRG neurons prompted us to express hSNSR4 in rat DRG neurons using recombinant adenoviruses. Adenoviruses expressing EGFP alone or coexpressing EGFP and hSNSR4 were constructed using the AdEasy system (He et al., 1998) . As shown in Figure 1 , A and D, application of BAM8 -22 (3 M) did not alter the amplitude of the double test pulse-evoked I Ca recorded from neurons expressing EGFP only (inhibition of HVA I Ca was 1.0 Ϯ 1.3%; n ϭ 5), consistent with the lack of effect in uninfected neurons. In neurons coexpressing EGFP and hSNSR4 ( Fig. 1 B, C) , application of BAM8 -22 induced robust inhibition of HVA I Ca (59.7 Ϯ 5.2%; n ϭ 16) (Fig. 1 D) . The inhibition was relatively rapid, reaching steady state within ϳ30 sec and reversed completely ϳ1 min after washout of the agonist. In contrast, as shown in Figure 1C , BAM8 -22 apparently did not inhibit significantly LVA I Ca recorded from neurons coexpressing hSNSR4 and EGFP (4.3 Ϯ 0.9%; n ϭ 5) (Fig. 1 D) .
A common form of fast HVA Ca 2ϩ channel inhibition is mediated by G␤␥ subunits released after activation of G i/o -proteins (for review, see Ikeda and Dunlap, 1999; Dolphin, 2003; Elmslie, 2003) . PTX has the ability to ADP-ribosylate a cysteine residue in the G␣ subunit of G i/o subfamily (four residues from the C terminus), thereby disrupting the coupling between these G-proteins and GPCRs. In neurons pretreated with PTX (500 ng/ml), the inhibition of I Ca evoked at ϩ10 mV by BAM8 -22 was significantly reduced (23.1 Ϯ 3.4%; n ϭ 12; p Ͻ 0.0001) (Fig.  1 D) . These data suggest that hSNSR4, when heterologously expressed in rat DRG neurons, can modulate HVA but not LVA Ca 2ϩ channels via both PTX-sensitive G i/o and PTX-insensitive G-proteins.
The ability of hSNSR4 to modulate HVA Ca 2ϩ channels is further illustrated by current-voltage ( I-V) relationships obtained in the absence or presence of BAM8 -22 (Fig. 2 B, C) . I Ca was evoked by 70 msec test pulses to successively increase potentials (ranging from Ϫ120 to ϩ80 mV) from a holding potential of Ϫ80 mV. I Ca arising from LVA Ca 2ϩ channels (T-type) displayed rapid, voltage-dependent inactivation, whereas I Ca arising from HVA Ca 2ϩ channels lacked rapid inactivation during a 70 msec step of depolarization. This is clearly demonstrated by representative records of I Ca (evoked by a 70 msec test pulse to Ϫ10 mV from holding potential at Ϫ80 mV) recorded from neurons that had predominantly LVA versus HVA (Fig. 2 A, left and right, respectively) current components. The I-V relationships shown in Figure 2 , B and C, were determined from I Ca amplitudes (same neuron as depicted in Fig. 1C ) measured near the beginning and end of the test pulses (i.e., 15 and 62.5 msec from the beginning of the test pulse, respectively). Because LVA channels inactivate rapidly, measurements at the end of the test pulse enhance visual separation of current components arising from LVA and HVA channels. In Figure 2C , the selective inhibition of the HVA I Ca component by BAM8 -22 is clearly illustrated.
Heterologously expressed hSNSR4 couples to voltagedependent Ca
2؉ channels in SCG neurons DRG neurons express multiple types of both LVA and HVA Ca 2ϩ channels. Hence, isolating an I Ca component arising from a single Ca 2ϩ channel type can be difficult. Moreover, the heterogeneity of primary sensory neurons in regard to expression of ion channels and GPCRs also complicates analysis. To circumvent these problems, we opted to use adult rat SCG neurons as expression hosts, because the composition of I Ca in these neurons is relatively homogeneous (primarily N-type Ca 2ϩ channels), and the modulation pathways are well described. Expression of hSNSR4 was achieved by directly injecting cDNA coding for the receptor into the nuclei of acutely dissociated SCG neurons (Ikeda, 2004) . Data in Figure 3 demonstrate that application of BAM8 -22 to neurons expressing hSNSR4, but not control (i.e., uninjected) neurons, inhibited I Ca evoked by a double-pulse voltage protocol (Fig. 3A, top) . The protocol (Elmslie et al., 1990) consisted of an initial 20 msec test pulse to ϩ10 mV ("prepulse") followed by a 50 msec depolarizing conditioning pulse to ϩ80 mV and a subsequent 20 msec test pulse to ϩ10mV ("postpulse"). Before application of the agonist, the postpulse current amplitude usually exceeded the prepulse amplitude recorded from control (i.e., uninjected) or hSNSR4 cDNA-injected neurons as shown in Figure  3 , A and B. This basal facilitation (defined as the ratio of postpulse to prepulse amplitude) has been shown previously to arise from tonic G-protein activation (Ikeda, 1991) . Application of BAM8 -22 (3 M) resulted in robust decrease of I Ca in neurons injected previously (18 -24 hr) with hSNSR4 cDNA, whereas BAM8 -22 at a higher concentration (10 M) was ineffective in control neurons. The inhibition was rapid and completely reversible as shown in Figure 3B . In SCG neurons, I Ca inhibition mediated by activation of GPCRs has been classified as either voltage dependent (VD) or voltage independent (VI). VD inhibition is mediated by G␤␥ (Herlitze et al., 1996; Ikeda, 1996) and can be relieved by strong depolarization (Bean, 1989; Elmslie et al., 1990 ). For example, as shown in Figure 3A and summarized in Figure 3D , the inhibition of prepulse I Ca in uninjected neurons after norepinephrine (NE; 10 M) application was robust (67.8 Ϯ 2.2%; n ϭ 7), whereas postpulse I Ca inhibition was much weaker (27.7 Ϯ 2.3%; n ϭ 7; p Ͻ 0.0001; paired t test). The mechanism of VI inhibition is more complex and less completely understood. Clearly, hSNSR4-mediated I Ca inhibition exhibits VD characteristics, because inhibition of prepulse I Ca amplitude by BAM8 -22 (66.6 Ϯ 2.6%; n ϭ 17) was much stronger than postpulse amplitude inhibition (44.8 Ϯ 3.4%; n ϭ 17; p Ͻ 0.0001; paired t test). However, although NE and BAM8 -22 induced virtually the same degree of prepulse I Ca inhibition (67.8 Ϯ 2.2%, n ϭ 7, and 66.6 Ϯ 2.6%, n ϭ 17, respectively), postpulse I Ca amplitude was differentially inhibited by NE and BAM8 -22 (27.7 Ϯ 2.3%, n ϭ 7, vs 44.8 Ϯ 3.4%, n ϭ 17; p Ͻ 0.001; t test). The fact that BAM8 -22 mediated I Ca inhibition was only partially alleviated (compared with NE-mediated I Ca inhibition) by the conditioning voltage step suggests that BAM8 -22-mediated I Ca inhibition arises from both VD and VI mechanisms.
The VD component of I Ca inhibition in SCG neurons is mediated by PTX-sensitive G-proteins GPCRs that mediate VD I Ca inhibition in SCG neurons usually couple to Ca 2ϩ channels via PTX-sensitive heterotrimeric G i/oproteins (Ikeda and Dunlap, 1999) . However, activation of some receptors linked to G s -proteins such as vasoactive intestinal polypeptide (VIP) receptor can also result in VD I Ca inhibition (Zhu and Ikeda, 1994) . To differentiate these possibilities, we tested the effect of overnight pretreatment with PTX (0.5 g/ml; 16 -24 hr) on hSNSR4-mediated I Ca inhibition. As shown in Figure 3C and summarized in Figure 3D , PTX pretreatment greatly attenuated BAM8 -22-mediated I Ca inhibition in neurons expressing hSNSR4. Interestingly, the onset of I Ca inhibition after PTX treatment also was much slower, taking ϳ2 min to achieve maximal inhibition. The mechanism responsible for this slow time course is unclear and deserves additional investigation. NEmediated I Ca inhibition was abolished in the same neurons establishing the activity of the toxin. The inhibition of I Ca by BAM8 -22 in neurons pretreated with PTX was VI, because inhibition of the prepulse amplitude (28.3 Ϯ 7.9%; n ϭ 5) was not significantly different from postpulse inhibition (22.9 Ϯ 7.5%; n ϭ 5; p ϭ 0.14; paired t test). As mentioned previously, in the absence of PTX pretreatment, prepulse and postpulse inhibitions were much greater (66.6 Ϯ 2.6 and 44.8 Ϯ 3.8%, respectively).
The finding that BAM8 -22-mediated I Ca inhibition arises from both VD and VI mechanisms also was supported by examining the relationship between hSNSR4-mediated I Ca inhibition and test potential (Fig. 4) . I-V relationships were obtained in the absence or presence of 3 M BAM8 -22 (Fig. 4 A) . The effect of voltage on hSNSR4-mediated inhibition is illustrated by the bellshaped relationship between I Ca inhibition and test potential (Fig. 4 B) . Maximal inhibition by BAM8 -22 in hSNSR4-expressing neurons occurs over a voltage range of 0 -10 mV. This was similar to NE-mediated inhibition of I Ca in control (uninjected) neurons (Fig. 4 B, open circles) . However, over the voltage range ϩ30 to ϩ60 mV, BAM8 -22-mediated inhibition was much greater than NE-mediated inhibition. Specifically, at ϩ42 mV, I Ca inhibition by BAM8 -22 in hSNSR4-expressing neurons was significantly greater (45.0 Ϯ 3.0%; n ϭ 7) than NE-mediated inhibition in control neurons (22.9 Ϯ 2.8%; n ϭ 5; p Ͻ 0.001; t test). Together, these data indicate that BAM8 -22-mediated I Ca inhibition in SCG neurons was comprised of two approximately equal components, VD inhibition mediated via PTX-sensitive G i/o -proteins and VI inhibition mediated via PTX-insensitive G-proteins.
Potency of BAM8 -22 in hSNSR4-expressing SCG neurons
To derive the concentration-response curve, I Ca was evoked every 10 sec using the voltage protocol depicted in Figure 3A . Figure 4C illustrates time courses of prepulse-evoked I Ca inhibition after sequential application of increasing concentration of BAM8 -22 recorded from SCG neurons expressing hSNSR4. Note that between agonist applications, I Ca amplitude rapidly (ϳ30 sec) recovered often beyond the baseline amplitude. Such "over recovery" after agonist application has been reported previously (Kasai, 1991) for I Ca inhibition, although the underlying mechanisms remain unclear. The EC 50 value for BAM8 -22 (0.60 M) was estimated by fitting mean I Ca inhibition data to the Hill equation (Fig. 4 D) using nonlinear regression. In uninjected neurons, BAM8 -22 at 10 M had no effect on I Ca amplitude (Fig. 3D) .
Constitutive activity of hSNSR4 in SCG neurons
In uninjected SCG neurons, the amplitude of I Ca evoked by the postpulse is usually slightly larger than that evoked by the prepulse. This basal facilitation has been attributed to tonic G-protein activation (Ikeda, 1991) . As summarized in Figure 5 , B and C, the basal facilitation ratio defined as the ratio of postpulse I Ca amplitude to prepulse I Ca amplitude in the absence of agonist ranged between 1.07 and 1.67 with a mean value of 1.30 Ϯ 0.02 (n ϭ 33) in uninjected neurons. During the course of these experiments, we noticed that a subset of hSNSR4-expressing neurons (19 of 65) exhibited a basal facilitation ratio that greatly exceeded that of the control group ( p Ͻ 0.0001), ranging from 1.70 to 2.17 with a mean of 1.88 Ϯ 0.04 (Fig. 5 A, B) . Additionally, as illustrated in Figure 5A , the activation kinetics of I Ca evoked by the prepulse was much slower than that of uninjected neurons (Fig. 3A) . Such kinetic slowing of current activation and strong VD facilitation are hallmarks of G␤␥-mediated inhibition of I Ca in SCG neurons (Ikeda and Dunlap, 1999) . The mean basal facilitation ratio derived from all hSNSR4-injected neurons (1.54 Ϯ 0.04; n ϭ 66) (Fig. 5 B, C) was also significantly higher than that of uninjected neurons ( p Ͻ 0.0001).
Additional experiments were performed to shed light on the increased basal facilitation ratio seen in a subset of hSNSR4-injected neurons. Injection of EGFP cDNA alone did not significantly alter basal facilitation ratio (1.17 Ϯ 0.03; n ϭ 6; data not shown) when compared with uninjected neurons ( p ϭ 0.24). Thus, the injection procedure and heterologous expression per se did not alter mean basal facilitation ratio. Pretreatment of hSNSR4-injected neurons with PTX (0.5 g/ml; 16 -24 hr) reduced the mean basal facilitation ratio to 1.38 Ϯ 0.04 (range, 1.19 -1.68; n ϭ 16) (Fig. 5 B, C) , a value comparable with that of uninjected cells ( p ϭ 0.27). Note that none of the PTX-treated hSNSR4-injected neurons or control neurons (including both uninjected and EGFP-expressing) had basal facilitation ratios Ͼ1.7, whereas 19 of 66 hSNSR4-injected cells (Fig. 5B ) exhibited basal facilitation ratios greater than this value. The effect of PTX on basal facilitation ratio in hSNSR4-expressing neurons suggests that in some neurons, hSNSR4 was active in the absence of overt agonist.
Heterologously expressed hSNSR4 couples to M-type K ؉ channels in SCG neurons
To test the hypothesis that hSNSR4 couples to G q/11 -proteins, we examined the modulation of M-type K ϩ channel currents (I M ) in SCG neurons. I M is a voltage-gated noninactivating K ϩ current (Brown and Adams, 1980 ) that influences neuronal excitability in both peripheral and central neurons. I M is modulated by GPCRs that couple to G q/11 via a mechanism involving activation of phospholipase C (PLC) and breakdown of phosphatidylinositol 4,5-bisphosphate (Suh and Hille, 2002; Zhang et al., 2003) .
Whole-cell I M from SCG neurons was recorded using pipette and external solutions that approximate physiological ion concentrations. Neurons were voltage clamped at a holding potential of Ϫ30 mV (which serves to inactivate other K ϩ channels found in SCG neurons) and periodically (0.1 Hz) stepped to Ϫ60 mV for 0.5 sec (Fig. 6 A) . I M amplitude was determined from the magnitude of the slow "tail current" resulting from M-channel deactivation during the voltage step to Ϫ60 mV. Application of BAM8 -22 (3 M) to uninjected neurons produced no detectable change in I M amplitude or time course (Fig. 6 A) . In neurons injected previously (18 -24 hr) with hSNSR4 cDNA, application of BAM8 -22 (3 M) resulted in a relatively fast (maximal inhibition at ϳ1 min after agonist application) and partially reversible inhibition (Fig. 6 B) . The inhibition was characterized by a dramatic decrease in both the steady-state outward current (measured before hyperpolarizing pulse) and the time-dependent current relaxation measured during the step to Ϫ60 mV (Fig. 6 B) . I M inhibition was determined by normalizing I M amplitude after 1 min of agonist application to the pre-drug amplitude. BAM8 -22-mediated I M inhibitions in uninjected and hSNSR4-injected neurons were Ϫ3.9 Ϯ 1.8% (n ϭ 5) and 87.3 Ϯ 2.7% (n ϭ 6), respectively (Fig. 6C) . PTX pretreatment (0.5 g/ml; 24 -26 hr) did not significantly attenuate BAM8 -22-mediated I M inhibition ( p ϭ 0.35) despite the fact that GPCRs linked to PTX-sensitive G i/o -proteins can activate some PLC-␤ isoforms via G␤␥ (Rhee, 2001) . The inhibition of I M amplitude in hSNSR4-injected neurons pretreated with PTX was 80.9 Ϯ 6.0% (n ϭ 7). These data demonstrate that hSNSR4, when heterologously expressed in SCG neurons, couples to M-type K ϩ channels via PTX-insensitive G-proteins.
Heterologously expressed hSNSR4 modulates synaptic transmission in rat hippocampal neurons
To test whether expression of hSNSR4 results in modulation of synaptic transmission, we used recombinant adenoviruses to coexpress the receptor and EGFP in hippocampal neurons grown in microisland culture (Fig. 7A) . This preparation has some favorable features for the study of synaptic transmission. Single neurons grown on isolated permissive microislands are forced to develop a large number of recurrent synaptic contacts (i.e., autapses), resulting in a large amplitude synaptic response and, consequently, a favorable signal-to-noise ratio and low variability. Additionally, autaptic responses are unambiguously monosynaptic. Conventional whole-cell patch-clamp techniques were used to record EPSCs from neurons that had been infected for 30 -60 hr. To evoke autaptic responses, hippocampal neurons were held at Ϫ60 mV (or in some cases at Ϫ40 mV to reduce driving force) and were stimulated every 10 sec with a pair of square depolarizing pulses (2 msec pulse, 60 mV, 50 msec interval between prepulse and postpulse). As shown in Figure 7 , B and D, application of BAM8 -22 (3 M) robustly inhibited prepulseevoked EPSCs in neurons coexpressing hSNSR4 and EGFP (55.9 Ϯ 4.9%; n ϭ 21), whereas the peptide was ineffective in neurons expressing EGFP alone (3.2 Ϯ 0.9%; n ϭ 6). The inhibition was relatively rapid, reaching nearly maximal inhibition within 30 sec and partially reversible after washout of the agonist (Fig. 7B) .
As shown in Figure 7B (top), in comparison with postpulseevoked EPSC, EPSCs evoked by the prepulse were more susceptible to BAM8 -22-mediated inhibition. This finding is more clearly illustrated in the plot of paired pulse facilitation ratio (PPR; the amplitude ratio of postpulse-over prepulse-evoked EPSCs) versus time (Fig. 7B, bottom) . BAM8 -22 induced a reversible increase of PPR that coincided with the peptide-induced inhibition of synaptic response. PPR is an indicator that has often been used to indirectly evaluate the release probability of synaptic vesicles (Manabe et al., 1993; Zucker and Regehr, 2002) . As summarized in Figure 7C , PPR in neurons expressing hSNSR4 was 1.24 Ϯ 0.07 (n ϭ 21) in the absence of agonist and markedly increased after application of BAM8 -22 (1.59 Ϯ 0.10; n ϭ 21; p Ͻ 0.001; paired t test). These data suggested that BAM8 -22-mediated inhibition of EPSCs in neurons expressing hSNSR4 was caused, at least in part, by a reduction in release probability of vesicles at presynaptic terminals.
The most common mechanism of GPCR-induced presynaptic inhibition is the inhibition of Ca 2ϩ channels by PTX-sensitive G i/o -proteins (Wu and Saggau, 1997) . Additionally, intracellular Ca 2ϩ stores may contribute to short-term synaptic plasticity in some cases (Galante and Marty, 2003 ; but see Carter et al., 2002 ). As shown above, when expressed in SCG or DRG neurons, hSNSR4 can couple to both PTX-sensitive G i/o and PTXinsensitive G-proteins. We thus tested the effect of pretreatment with PTX (100 ng/ml; Ͼ24 hr) on EPSC inhibition. As summarized in Figure 7D , PTX treatment abolished BAM8 -22-induced inhibition of prepulse-evoked EPSCs in neurons expressing hSNSR4 (Ϫ6.7 Ϯ 3.2%; n ϭ 11; p ϭ 0.29; in comparison with control EGFP-expressing neurons) after adenovirus infection. Interestingly, application of BAM8 -22 to one neuron expressing hSNSR4 resulted in an increase of prepulse-evoked EPSC amplitude (27.8%) with accompanying reduction of PPR from 1.63 to 1.34, indicating an increased release probability. Together, these data suggest activation of hSNSR4 after adenoviral infection can induce inhibition of transmitter release mediated by PTXsensitive G i/o -proteins.
Discussion
SNSRs/mgrXs are a new family of human GPCRs with an expression profile restricted to small nociceptors of primary sensory ganglia. Their unique expression pattern raises the exciting possibility that SNSRs/mgrXs may provide novel targets for the development of improved analgesic agents, although at present, their neuronal function is unknown. Unlike the great majority of human GPCRs, orthologs of SNSRs/mgrXs probably do not exist in rodents, and the gene family appears to have undergone rapid and divergent evolution (Choi and Lahn, 2003; Zylka et al., 2003) . This divergence makes it difficult to assess physiological functions by studying natively expressed receptors in rodent sensory ganglia or using murine gene knock-out technology. As a first step toward understanding the neuronal function of this family of receptors, we used recombinant adenoviral infection and nuclear injection techniques to express one of the human SNSRs/mrgXs, hSNSR4, in cultured rat neurons and found that the receptor can modulate neuronal ion channels as well as synaptic transmission.
Consistent with molecular screening efforts (Dong et al., 2001; Lembo et al., 2002) and bioinformatics searches (Zylka et al., 2003 ) that failed to identify rodent orthologs of human SNSRs, application of BAM8 -22, a potent peptide agonist of human SNSR3/4, did not alter the amplitude of HVA and LVA I Ca in a number (n ϭ 41) of control rat and mouse DRG neurons. In contrast, the peptide was highly effective in modulating HVA I Ca but had little or no effect on I Ca arising from LVA (T-type) Ca 2ϩ channels in acutely dissociated rat DRG neurons that had been infected with adenoviruses coexpressing both EGFP (as a marker) and hSNSR4. These data establish that hSNSR4 efficiently couples to pre-existing Ca 2ϩ channels and signaling components after heterologous expression. Our data suggest that orthologs of human SNSR3/4 do not exist in rodent primary sensory neurons as previously predicted. However, it should be noted that BAM8 -22 [termed BAM-15 by Han et al. (2002) ] is a fairly potent agonist for (murine) mrgC11, and a rat ortholog of this receptor has been predicted. Thus, GPCRs responsive to BAM8 -22 may exist in rodent neurons but expressed in an extremely small subset of sensory neurons or targeted to a cellular location such as peripheral or central terminals not accessible in our preparation. However, our results demonstrate unequivocally that heterologously expressed hSNSR4s couple to native Ca 2ϩ channels using endogenous signaling pathways. Ligandbinding assays using radioactive BAM8 -22 or immunochemistry using antibodies generated against human SNSRs should help resolve this issue.
Primary sensory neurons express multiple types of Ca 2ϩ channels, including T-, N-, P/Q-, R-, and L-types (Fedulova et al., 1985; Fox et al., 1987; Kostyuk et al., 1988; Regan et al., 1991; Mintz et al., 1992) . From our data, it is not clear which type(s) of HVA Ca 2ϩ channels is subjected to the inhibition after activation of hSNSR4, although one assumes that N-and P/Q-type Ca 2ϩ channels are involved because these channel types are highly modulated by GPCRs. LVA Ca 2ϩ channels apparently were not affected by hSNSR4 activation. This result is interesting within the context of a recent study (Wolfe et al., 2003) demonstrating that T-type Ca 2ϩ channels are modulated by a specific G␤␥ combination, namely G␤ 2 ␥ 2 . To study hSNSR4-mediated modulation on a defined HVA Ca 2ϩ channel subtype, receptors were expressed in rat SCG neurons. Ca 2ϩ channels in this system are homogeneous and consist of current arising primarily from N-type Ca 2ϩ channels (Ikeda, 1991) . Application of BAM8 -22 induced robust inhibition (66.6%) of I Ca in SCG neurons previously injected with expression vectors encoding hSNSR4, whereas the peptide was ineffective in control neurons. The finding that hSNSR4 modulates N-type Ca 2ϩ channels might be physiologically relevant, because evoked transmitter release at excitatory synapses formed between small-diameter nociceptors and the neurons located in layers I and II of the spinal dorsal horn are controlled primarily by Ca 2ϩ influx via N-type Ca 2ϩ channels (Bao et al., 1998; Craig, 2003) .
We also found that BAM8 -22-induced I Ca inhibition in SCG neurons was comprised of approximately two equal components: VD inhibition mediated by PTX-sensitive G i/o -proteins and VI inhibition mediated by PTX-insensitive G-proteins. VI inhibition in SCG neurons is usually mediated by G q/11 -proteins (Kammermeier et al., 2000; Dolphin, 2003) . Additionally, application of the peptide nearly abolished the current derived from M-type K ϩ channels in SCG neurons heterologously expressing hSNSR4, whereas it was ineffective in control SCG neurons. I M is a noninactivating, voltage-dependent K ϩ conductance that has been found to play an important role in controlling neuronal excitability (Brown and Adams, 1980) . Thus far, only G q/11 -coupled receptors (under native conditions) have been found to inhibit I M . Consistent with this, we found that pretreatment with PTX did not alter BAM8 -22-induced inhibition of I M . I M has been recorded from many types of central and peripheral neurons, but it was not until recently that the presence of I M in mammalian primary sensory neurons was documented and shown to be involved in chronic pain transmission (Passmore et al., 2003) . If sensory neurons in humans also express I M channels, then the coupling of hSNSR4 to I M , as shown here, might have relevance to human nociceptive pathways. These data indicate that hSNSR4 can couple to both G i/o -proteins and PTX-insensitive G-proteins, most likely G q/11 . Because G q/11 -coupled receptors such as bradykinin receptors can sensitize the heat-responsive vanilloid receptor VR1 (Chuang et al., 2001) , it would be interesting to test whether hSNSR4 modulates the function of VR1.
Thus far, ϳ40 mrg gene family members with intact coding from the same neurons in the absence or presence of BAM8 -22. I M amplitude was determined as the current component deactivating during a 500 msec voltage step to Ϫ60 mV (arrows in A, top). C, hSNSR4-mediated inhibition of I M was insensitive to overnight pretreatment with PTX (0.5 g/ml). Mean (ϮSEM) percentage I M inhibition was produced by application of BAM8 -22 under the conditions indicated. I M inhibition was determined from traces acquired just before and 1 min after the start of agonist application. The number of neurons tested is indicated in parentheses. Uninj., Uninjected.
sequences have been reported. Potent agonists have been discovered for seven members (including hSNSR4), thereby facilitating studies of how receptor activation influences intracellular [Ca 2ϩ ] and cAMP levels in mammalian cell lines. Results from these experiments indicate that human SNSR3, hSNSR4 (mrgX1), and mrgX2, and murine mrgA1, mrgA10, and mrgC11 signal via G q/11 -but probably not G i/o -or G s -proteins (Dong et al., 2001; Han et al., 2002; Lembo et al., 2002; Robas et al., 2003) , whereas the rat adenine receptor (a likely ortholog of murine mrgA10) can couple to G i/o -proteins (Bender et al., 2002) . Here, we demonstrated that hSNSR4, when expressed in rat neurons, couples to both PTXinsensitive (most likely G q/11 ) and PTXsensitive (G i/o family) G-proteins. This is the first demonstration, to our knowledge, of the pleiotropic G-protein-coupling potential of mrg genes.
In a subset of SCG neurons heterologously expressing hSNSR4, the receptor appeared in the absence of overt agonist to inhibit Ca 2ϩ channels in a voltagedependent manner. This "constitutive activity" was not seen in PTX-pretreated neurons, indicating a requirement for the activation of G i/o -proteins and ruling out a simple upregulation of basal G␤␥ expression as a source of the activity. Because our assay relies on strong depolarizationinduced relief of inhibition, constitutive VI Ca 2ϩ channel inhibition, if present, would not be detected. Therefore, we cannot rule out the possibility that hSNSR4 also constitutively activates G q/11 -proteins, although the basal I M amplitude in SCG neurons was not significantly altered by expression of the receptor ( p ϭ 0.14; data not shown). Constitutive activity has been found in Ͼ60 wild-type or mutant GPCRs and can cause diseases in some cases (Seifert and Wenzel-Seifert, 2002) . The significance of the constitutive activity of hSNSR4 remains unknown. Interestingly, it was reported recently that nociceptin receptors in rat DRG neurons constitutively inhibit the Ca 2ϩ channel function (perhaps via a direct physical interaction) and that this activity may contribute to the mechanisms of nociceptive signaling (Beedle et al., 2004) .
Finally, we also examined the potential role of hSNSR4 in synaptic neurotransmission. Activation of hSNSR4 heterologously expressed in hippocampal neurons induced marked inhibition of synaptic responses. The inhibition was abolished by PTX pretreatment, indicating that it was mediated by G i/oproteins. Additionally, the inhibition was associated with an increase in paired-pulse facilitation, thus suggesting a presynaptic locus of action. From these results, it is clear that hSNSR4 can traffic to presynaptic nerve terminals, couple to native signaling proteins, and interact with the release apparatus to alter synaptic transmission. If analogous processes occur in human DRG neurons, SNSRs could play a role in pain message signaling in vivo. 
